Prescription drug · ANDA
Glycopyrrolate NDC 71872-7012
Glycopyrrolate .2 mg/mL · Injection · Intramuscular, Intravenous · Medical Purchasing Solutions, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71872-7012-1 | 71872701201 | 10 VIAL in 1 BAG (71872-7012-1) / 20 mL in 1 VIALMarketed from Feb 28, 2018 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Glycopyrrolate
- Generic name (nonproprietary)
- glycopyrrolate
- Active ingredients
- Glycopyrrolate — .2 mg/mL
- Dosage form
- Injection
- Route
- Intramuscular, Intravenous
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207639
- Marketing start
- Listing expires
- Other FDA classes
- Cholinergic Antagonists (Mechanism)
- Identifiers
- Product ID 71872-7012_fd1a6beb-7da4-5539-e053-6394a90ab391SPL ID fd1a6beb-7da4-5539-e053-6394a90ab391SPL set ID 66726c2b-27e8-5dd1-e053-2991aa0a1ba7RxCUI 238212UNII V92SO9WP2IUPC 0371872701211
- Pharmacologic class
- Anticholinergic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N471872701201followed by a unit qualifier and the quantityPackage 71872-7012-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.
Other NDCs under ANDA 207639
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | Medical Purchasing Solutions, LLC | 71872-7094 |
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | Medical Purchasing Solutions, LLC | 71872-7093 |
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | SolutionIntramuscular, Intravenous | Somerset Therapeutics, LLC | 70069-619 |
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | SolutionIntramuscular, Intravenous | Somerset Therapeutics, LLC | 70069-616 |
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | SolutionIntramuscular, Intravenous | Somerset Therapeutics, LLC | 70069-617 |
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | SolutionIntramuscular, Intravenous | Somerset Therapeutics, LLC | 70069-618 |